Modernization and Patient Demand: Factors Driving Chinese Fibromyalgia Market Growth in Chronic Care
The accelerating Chinese Fibromyalgia Market growth is largely a function of the rapid modernization of China's healthcare system and the shifting expectations of its patient population. A key driver is the professionalization of rheumatology and pain management, with more clinicians being trained in Western protocols that formally recognize and diagnose fibromyalgia. This institutional shift...
0 Comments 0 Shares 189 Views 0 Reviews